Ticker: RAPP

Rapport Therapeutics, Inc. (NASDAQ: RAPP) - Company Overview Rapport Therapeutics is a clinical-stage biotechnology company located in Boston, Massachusetts, focused on developing small molecule precision medicines for neurological disorders, including focal epilepsy and bipolar disorder. The com...